This inventor holds 1 USPTO granted patent. Top assignee: Leland Stanford Junior University. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Elizabeth Qin: Innovator in Glioma Treatment
Introduction
Elizabeth Qin is a prominent inventor based in Palo Alto, California. She has made significant contributions to the field of medical research, particularly in the treatment of glioma, a type of brain tumor. Her innovative work focuses on targeting pleiotrophin signaling to limit high-grade glioma invasion.
Latest Patents
Elizabeth Qin holds a patent for her invention titled "Targeting pleiotrophin signaling to limit high-grade glioma invasion." This patent discloses compositions and methods for the treatment of glioma. Specifically, the invention relates to methods of treating glioma by inhibiting pleiotrophin signaling to limit high-grade glioma invasion. She has 1 patent to her name.
Career Highlights
Elizabeth Qin is affiliated with Leland Stanford Junior University, where she conducts her research. Her work has garnered attention for its potential to improve treatment outcomes for patients suffering from glioma.
Collaborations
One of her notable collaborators is Michelle Monje-Deisseroth, who is also a respected figure in the field of neuroscience. Their partnership highlights the importance of teamwork in advancing medical research.
Conclusion
Elizabeth Qin's innovative approach to glioma treatment exemplifies the impact of targeted therapies in modern medicine. Her contributions are paving the way for new treatment options for patients facing this challenging condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile